Asia Press Agency

Tag: Max Life Insurance

  • Subramanian Swamy Alleges ₹5,100 Crore Scam

    Subramanian Swamy Alleges ₹5,100 Crore Scam

    Subramanian Swamy, a senior leader of the Bharatiya Janata Party (BJP), has brought forth serious allegations of a scam involving Axis Bank’s dealings with Max Life Insurance Company. In a public interest litigation (PIL) filed with the Delhi High Court, Swamy claims that Axis Bank orchestrated a scam worth approximately ₹5,100 crore through its sale and purchase of shares in Max Life Insurance. The PIL sheds light on the intricacies of the transactions between Axis Bank, Max Life, and other entities, alleging significant discrepancies and unfair gains.

     

    Max Life Insurance, a prominent player in the Indian insurance sector, operates as a joint venture between Max Financial Services and Axis Bank. The controversy stems from Axis Bank’s proposal to purchase an additional 7% stake in Max Life, amounting to ₹1,612 crore, which received approval from the Insurance Regulatory and Development Authority of India (Irdai) on 6th February. This move would increase Axis Bank’s collective ownership in Max Life to 19.02%, up from its current stake of less than 13%.

     

    Swamy’s petition outlines a series of transactions conducted by Axis Bank between February 2016 and April 2021, alleging that the bank profited substantially from these deals. For instance, the petition highlights a scenario where Axis Bank sold its stake of 0.998% in Max Life to Max Financial Services Ltd and Mitsui Sumitomo International at ₹166 per share. Shortly thereafter, between March and April 2021, Axis Bank and its affiliated entities acquired a 12.002% stake from Max Financial Services at a significantly lower price range of ₹31.51-32.12 per share. Swamy argues that these transactions resulted in exorbitant gains for Axis Bank, as the selling price far exceeded the initial purchase price.

     

    In response to the allegations, Axis Bank has vehemently denied any wrongdoing, dismissing Swamy’s claims as unfounded and devoid of merit. The bank asserts that it obtained all necessary regulatory approvals for the sale and purchase of Max Life shares, emphasizing its commitment to compliance and ethical conduct. Similarly, Max Life has defended the legality of the transactions, stating that they were conducted with the requisite approvals from regulatory authorities such as the RBI, Irdai, and CCI. Both Axis Bank and Max Life have expressed their intent to defend against the allegations and uphold their respective positions before the court.

     

    Subramanian Swamy’s petition further implicates Max Financial Services Ltd and Mitsui Sumitomo International, alleging collusion in facilitating transactions that unfairly favored Axis Bank. He contends that these dealings contravened the directives of Irdai and constituted a blatant fraud perpetrated by Max Life Insurance and Max Financial Services. Subramanian Swamy argues that an independent investigation by a panel of experts is warranted to probe the alleged irregularities and hold the responsible parties accountable.

     

    The matter is scheduled for hearing before a division bench of the Delhi High Court on 13th March. Regulatory bodies such as the Securities and Exchange Board of India (Sebi), Reserve Bank of India (RBI), and Irdai have been named as respondents in the case, along with Axis Bank, its affiliates, and Max Life. Senior counsel Mukul Rohatgi represents the Axis group, while Swamy is represented by senior advocate Rajshekhar Rao.

     

    As the legal battle unfolds, the allegations leveled by Swamy have cast a shadow of doubt over the integrity of Axis Bank’s dealings with Max Life Insurance. The outcome of the court proceedings will not only determine the accountability of the parties involved but also have broader implications for the regulatory framework governing corporate transactions in the insurance sector.

  • Subramanian Swamy Alleges ₹5100 Crore Scam in Axis Bank

    Subramanian Swamy Alleges ₹5100 Crore Scam in Axis Bank

    Former Rajya Sabha MP and BJP leader Subramanian Swamy has taken a significant step by moving the Delhi High Court, alleging a scam of nearly ₹5100 crore involving Axis Bank, as reported by Bar and Bench. Swamy has accused the private lender of making undue gains through transactions in shares of Max Life Insurance, prompting him to seek a thorough investigation into the matter.

     

    In his plea before the court, Swamy has laid out several allegations against Axis Bank and its associated entities. He has called for the formation of a committee consisting of experts to investigate the fraudulent acts he claims to have uncovered. The alleged scam revolves around transactions involving shares of Max Life Insurance, with Swamy contending that Axis Bank and its group companies, namely Axis Securities Ltd and Axis Capital Ltd, made significant profits in a non-transparent manner.

     

    According to Swamy’s plea, the actions of Max Life Insurance Co. Ltd and Max Financial Services Ltd, in conjunction with Axis Bank Ltd, constitute a misuse of power and a breach of regulatory requirements. Swamy asserts that there was a deliberate attempt to manipulate the system to enable Axis Bank and its affiliates to reap unjustified profits from the purchase and sale of equity shares of Max Life.

     

    The plea further alleges that Axis Bank, leveraging its dual role as a shareholder and corporate agent of Max Life, engaged in activities that violated regulatory norms and led to illegal profiteering. Swamy contends that despite previous penalties imposed on Axis Bank for similar violations, the institution continued to engage in questionable practices, necessitating a thorough investigation into its recent transactions.

     

    Swamy’s plea seeks not only an investigation into the alleged scam but also the formulation of comprehensive guidelines to prevent similar incidents in the future. He emphasizes the need for regulatory authorities to take decisive action against instances of corruption and malpractice in the banking and insurance sectors to uphold the rule of law and protect the interests of consumers.

     

    The plea underscores the importance of transparency and accountability in the financial industry, particularly in dealings involving significant sums of money. Swamy’s decision to approach the Delhi High Court reflects his commitment to combating corruption and ensuring that those responsible for fraudulent activities are held accountable.

     

    In response to Swamy’s plea, the court has directed him to serve copies of the petition to all respondents and has scheduled the matter for further hearing on March 13, 2024. The involvement of senior advocates on both sides indicates the gravity of the allegations and the legal complexities involved in adjudicating the case.

     

    Overall, Swamy’s move to seek judicial intervention in the alleged scam involving Axis Bank and Max Life Insurance underscores the importance of regulatory oversight and enforcement in safeguarding the integrity of the financial system and protecting the interests of stakeholders.

  • Max Life Insurance Introduces ‘Max Life NIFTY Smallcap Quality Index Fund’

    Max Life Insurance Introduces ‘Max Life NIFTY Smallcap Quality Index Fund’

    Max Life Insurance Company Ltd. (“Max Life”/”Company”) has launched the ‘NIFTY Smallcap Quality Index Fund’ (SFIN:ULIF02702/08/23NIFTYSMALL104) in the ULIP segment. This first Smallcap Index Fund of the Life Insurance industry is based on the NIFTY Smallcap 250 Quality 50 Index that has delivered 22% 10-year CAGR+. It is designed to provide investors with an opportunity to capitalize on the growth potential of Smallcap companies, aiming for long-term index-linked returns. The New Fund Offer (NFO) window will remain open till 25th August 2023, at Rs. 10 per unit, applicable only during the NFO period.

     

    Mihir Vora, Senior Director and Chief Investment Officer, Max Life said, “We are launching our first-ever Smallcap Index Fund to offer investors a low-cost value proposition. The Fund provides an excellent opportunity to participate in the India growth story by investing in quality companies in diverse sectors with a high growth potential. Over the past years, the small-cap and mid-cap indices have given stellar returns. This Fund is suited for investors with high-risk tolerance looking to generate good returns over the long term. We are launching the Fund at a time when the Indian economy expects to do well over the coming years, and investors can take part in the growth of manufacturing, infrastructure, consumption, financials, and new-tech space.”

     

    A unique proposition of lower Fund Management Charges (FMC) makes this Index Fund a valuable investment avenue for millennial investors. The Fund will be available with the leading product – Online Savings Plan with zero allocation and admin charges, along with the Platinum Wealth Plan available with guaranteed wealth boosters and additions during the NFO period. The Fund will also be available with some other ULIP products. Closely tracking the total returns of the NIFTY Smallcap 250 Quality 50 Index subject to investment norms stipulated by IRDAI, this new Fund is expected to generate similar returns as of the benchmark returns*.

     

    Max Lifes equity investment strategy embraces the growing interest in the small-cap category, recognizing its potential for higher growth prospects for India and these companies.

     

    About Max Life Insurance : Max Life Insurance Company Limited is a Joint Venture between Max Financial Services Limited and Axis Bank Limited. Max Financial Services Ltd. is a part of Max Group. Max Life offers comprehensive protection and long-term savings life insurance solutions, through its multi-channel distribution including agency and third-party distribution partners. Max Life has built its operations over two decades through a need-based sales process, a customer-centric approach to engagement and service delivery and trained human capital. As per annual audited financials for FY 2022-23, Max Life has achieved a gross written premium of INR 25,342 Cr.

     

    These are returns of benchmark index as on 24th July, 2023, and are not indicative returns of Max Life Insurance’s newly launched NIFTY Smallcap Quality Index Fund (SFIN: ULIF02702/08/23NIFTYSMALL104). Illustratively, Rs. 1 Lac invested in the index in 2013 would have become Rs. 7.3 Lac in 2023. * However, basis due expenses, portfolio deviations (because of timing of investments/flows), the returns of fund and benchmark may differ. The premium shall be adjusted on the due date even if it has been received in advance.

     

    THE UNIT LINKED INSURANCE PRODUCTS DO NOT OFFER ANY LIQUIDITY DURING THE FIRST FIVE YEARS OF THE CONTRACT. THE POLICYHOLDER WILL NOT BE ABLE TO SURRENDER/WITHDRAW THE MONIES INVESTED IN UNIT LINKED INSURANCE PRODUCTS COMPLETELY OR PARTIALLY TILL THE END OF FIFTH YEAR.

     

    Unit Linked Insurance Products (ULIPS) are different from the traditional insurance products and are subject to the risk factors. The premium paid in the Unit Linked Life Insurance Policies is subject to investment risks associated with capital markets and the NAVs of the units may go up or down based on the performance of fund and factors influencing the capital market and the insured is responsible for his/her decisions.

     

    Max Life Insurance Company Limited is only the name of the insurance company and Max Life Platinum Wealth Plan is only the name of the unit linked insurance contract and does not in any way indicate the quality of the contract, its future prospects or returns. The premiums & funds are subject to certain charges related to the fund or to the premium paid. Past performance of the investment funds do not indicate the future performance of the same. Investors in the Scheme are not being offered any guaranteed/assured returns.